Announced Wed, 1 Apr · 17:23 IST
Promoter group allots 11.7L convertible warrants via preferential issue
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹774.50
prior close
₹768.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-1.3-1.8-0.9+0.5-0.6+1.2+3.7+5.9+10.1+21.4+15.0+37.5+72.4
Up moveDown movePending
AI summary
The promoter group of Senores Pharmaceuticals received 11,70,000 convertible equity warrants through a preferential allotment on March 28, 2026. This raises their total holding from 21,100,357 shares (45.82%) to 22,270,357 shares (47.16% on diluted basis). Equity share capital stays at ₹46.05 crore (4.6 crore shares); diluted share capital expands to ₹47.22 crore (4.72 crore shares). No encumbrance or open-market deals reported.
Likely market impact
Signals promoter confidence via preferential investment. Minor dilution from warrant conversion; promoter holding stays below 50%.